Shandong Boan Biotechnology バランスシートの健全性
財務の健全性 基準チェック /36
Shandong Boan Biotechnology has a total shareholder equity of CN¥1.4B and total debt of CN¥654.2M, which brings its debt-to-equity ratio to 47%. Its total assets and total liabilities are CN¥2.5B and CN¥1.2B respectively. Shandong Boan Biotechnology's EBIT is CN¥19.8M making its interest coverage ratio 1. It has cash and short-term investments of CN¥172.1M.
主要情報
47.0%
負債資本比率
CN¥654.23m
負債
| インタレスト・カバレッジ・レシオ | 1x |
| 現金 | CN¥172.12m |
| エクイティ | CN¥1.39b |
| 負債合計 | CN¥1.16b |
| 総資産 | CN¥2.55b |
財務の健全性に関する最新情報
更新なし
財務状況分析
短期負債: 6955's short term assets (CN¥749.0M) exceed its short term liabilities (CN¥555.6M).
長期負債: 6955's short term assets (CN¥749.0M) exceed its long term liabilities (CN¥601.0M).
デット・ツー・エクイティの歴史と分析
負債レベル: 6955's net debt to equity ratio (34.6%) is considered satisfactory.
負債の削減: Insufficient data to determine if 6955's debt to equity ratio has reduced over the past 5 years.
債務返済能力: 6955's operating cash flow is negative, therefore debt is not well covered.
インタレストカバレッジ: 6955's interest payments on its debt are not well covered by EBIT (1x coverage).